Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q1 2025
Institutional positions in Sunshine Biopharma Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −1 vs. Q4 2024
- Shares held
- 79.4K
- +58.8K (+285.9%) vs. Q4 2024
- Total value
- $151.7K
- +$90.0K (+145.7%) vs. Q4 2024
- New holders
- 1
- 3 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 15 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 50,466 | $96.4K | 0.28% | +50,466 | New |
| UBS Group AG | 19,885 | $38.0K | 0.00% | +19,017+2,190.9% | Added |
| SBI Securities Co., Ltd. | 5,223 | $9.98K | 0.00% | +4,514+636.7% | Added |
| Morgan Stanley | 3,834 | $7.32K | 0.00% | −3,806−49.8% | Reduced |
| National Bank of Canada | 10 | $19 | 0.00% | +3+42.9% | Added |
| Bank of America Corp | 5 | $10 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Rise Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −11,345−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |